We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.82B
AUM Growth
+$107M
Cap. Flow
+$23.3M
Cap. Flow %
1.28%
Top 10 Hldgs %
39.13%
Holding
257
New
14
Increased
66
Reduced
107
Closed
3

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$63.3M
2
IBM icon
IBM
IBM
+$13.1M
3
AAPL icon
Apple
AAPL
+$5.85M
4
DT icon
Dynatrace
DT
+$5.53M
5
EA icon
Electronic Arts
EA
+$3.17M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$14.5M
2
KLAC icon
KLA
KLAC
+$6.01M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$5.52M
4
KO icon
Coca-Cola
KO
+$5.3M
5
CSCO icon
Cisco
CSCO
+$3.54M

Sector Composition

Rank Sector Weight
1 Technology 25.36%
2 Consumer Staples 18.2%
3 Healthcare 13.43%
4 Financials 11.81%
5 Consumer Discretionary 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
26
Cisco
CSCO
$456B
$17.5M 0.96%
338,744
-72,050
-18% -$3.54M
PAYX icon
27
Paychex
PAYX
$42.3B
$17.4M 0.95%
155,195
-20,470
-12% -$2.24M
RTX icon
28
RTX Corp
RTX
$295B
$16.4M 0.9%
167,547
+2,611
+2% +$256K
GOOGL icon
29
Alphabet (Google) Class A
GOOGL
$4.08T
$16.3M 0.9%
136,137
-47,975
-26% -$5.52M
SBUX icon
30
Starbucks
SBUX
$118B
$14.4M 0.79%
145,507
+2,550
+2% +$265K
ACN icon
31
Accenture
ACN
$101B
$13.6M 0.75%
44,064
-8,698
-16% -$2.53M
AMAT icon
32
Applied Materials
AMAT
$378B
$13M 0.71%
89,979
+2,556
+3% +$320K
WST icon
33
West Pharmaceutical
WST
$23.7B
$13M 0.71%
34,000
NEE icon
34
NextEra Energy
NEE
$186B
$12.7M 0.7%
170,974
-6,242
-4% -$473K
LMT icon
35
Lockheed Martin
LMT
$134B
$12.5M 0.69%
27,198
+4,206
+18% +$1.95M
UNH icon
36
UnitedHealth
UNH
$389B
$12.5M 0.69%
26,020
-665
-2% -$325K
MS icon
37
Morgan Stanley
MS
$333B
$12.5M 0.69%
145,919
+5,351
+4% +$458K
MDT icon
38
Medtronic
MDT
$111B
$12M 0.66%
136,315
-8,085
-6% -$696K
TJX icon
39
TJX Companies
TJX
$178B
$12M 0.66%
141,356
-36,675
-21% -$2.89M
VZ icon
40
Verizon
VZ
$201B
$11.9M 0.66%
320,822
+4,645
+1% +$172K
PFE icon
41
Pfizer
PFE
$144B
$11.6M 0.64%
316,610
-9,014
-3% -$351K
CTVA icon
42
Corteva
CTVA
$59.5B
$11.5M 0.63%
200,968
-19,560
-9% -$1.14M
CVS icon
43
CVS Health
CVS
$140B
$11.3M 0.62%
163,790
-31,753
-16% -$2.26M
ORCL icon
44
Oracle
ORCL
$346B
$11.1M 0.61%
93,356
-140,499
-60% -$14.5M
UPS icon
45
United Parcel Service
UPS
$89.7B
$10.9M 0.6%
60,757
+4,309
+8% +$765K
ABT icon
46
Abbott
ABT
$187B
$10.7M 0.59%
97,925
-3,185
-3% -$340K
PLD icon
47
Prologis
PLD
$137B
$10.6M 0.58%
86,315
+4,243
+5% +$522K
COST icon
48
Costco
COST
$429B
$10.5M 0.58%
19,505
-1,705
-8% -$863K
MET icon
49
MetLife
MET
$62.7B
$10.4M 0.57%
183,721
-14,002
-7% -$777K
GOOG icon
50
Alphabet (Google) Class C
GOOG
$4.07T
$10.2M 0.56%
84,680
+12,400
+17% +$1.44M

Similar funds

Cullinan Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Cullinan Associates held 257 positions worth $1.82B, up 6.3% from $1.71B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Cullinan Associates's Q2 2023 filing shows 14 new, 66 increased, 107 reduced and 3 closed positions. Its largest new stake was Dynatrace: 118,036 shares worth $6.08M. The largest sale was Oracle, an estimated $14.5M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Cullinan Associates's largest Q2 2023 buy was Dynatrace: 118,036 shares worth $6.08M.
  • Cullinan Associates added most to Walmart Inc in Q2 2023, an estimated $63.3M increase.
  • Cullinan Associates's biggest Q2 2023 reduction was Oracle, cutting an estimated $14.5M.
  • Cullinan Associates fully exited Marriott International in Q2 2023, selling an estimated $421K.
  • Cullinan Associates's ten largest holdings make up 39% of its $1.82B portfolio in Q2 2023.
  • Cullinan Associates opened 14 new positions and closed 3 in Q2 2023.
  • Cullinan Associates's portfolio value rose 6.3% quarter-over-quarter to $1.82B.

Based on Cullinan Associates's 13F filing for Q2 2023, filed 14 Jul 2023.